Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitals.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 15 04 2024
accepted: 11 07 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: epublish

Résumé

The risk of venous thromboembolism (VTE) increases with age. However, the risk of VTE in the setting of long-term care hospitals is understudied. Our objective was to provide data on the prevalence and incidence of VTE in older adults admitted to long-term care hospitals. In this retrospective cohort study, we collected data about chronically ill and multimorbid patients aged 65 years and older from two long-term care hospitals. The primary endpoint of this study was the lifetime prevalence of VTE, and the secondary endpoint was VTE incidence during residency in long-term care hospitals. We analysed data from 1148 patients with a mean age of 84.1 ± 7.9 years, of whom 74.2% were women. The lifetime prevalence of VTE at baseline was 9.6% (95% CI 7.9-11.4). Cumulative incidence of VTE at 1, 2, and 3 years from baseline was estimated at 3.5% (95% CI 2.5-4.7), 4.2% (95% CI 3.1-5.5), and 5.4% (95% CI 4.1-7.0), respectively. Overall, the incidence rate of VTE in our study was 2.82 (95% CI 2.18-3.66) per 100 person-years. The study indicated a considerably high lifetime prevalence and incidence of VTE during residence in long-term care hospital settings, requiring further evaluation in larger prospective studies.

Identifiants

pubmed: 39085300
doi: 10.1038/s41598-024-67480-1
pii: 10.1038/s41598-024-67480-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17737

Informations de copyright

© 2024. The Author(s).

Références

Næss, I. A. et al. Incidence and mortality of venous thrombosis: A population-based study. J. Thromb. Haemost. 5, 692–699. https://doi.org/10.1111/j.1538-7836.2007.02450.x (2007).
doi: 10.1111/j.1538-7836.2007.02450.x pubmed: 17367492
Raskob, G. E. et al. Thrombosis: A major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol. 34, 2363–2371. https://doi.org/10.1161/ATVBAHA.114.304488 (2014).
doi: 10.1161/ATVBAHA.114.304488 pubmed: 25304324
Tagalakis, V., Patenaude, V., Kahn, S. R. & Suissa, S. Incidence of and mortality from venous thromboembolism in a real-world population: The Q-VTE study cohort. Am. J. Med. 126(832), e813-832.e821. https://doi.org/10.1016/j.amjmed.2013.02.024 (2013).
doi: 10.1016/j.amjmed.2013.02.024
Kahn, S. R. et al. The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation 130, 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 (2014).
doi: 10.1161/CIR.0000000000000130 pubmed: 25246013
Klok, F. A. et al. The post-PE syndrome: A new concept for chronic complications of pulmonary embolism. Blood Rev. 28, 221–226. https://doi.org/10.1016/j.blre.2014.07.003 (2014).
doi: 10.1016/j.blre.2014.07.003 pubmed: 25168205
Prandoni, P. et al. The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 125, 1–7. https://doi.org/10.7326/0003-4819-125-1-199607010-00001 (1996).
doi: 10.7326/0003-4819-125-1-199607010-00001 pubmed: 8644983
Tran, A., Redley, M. & de Wit, K. The psychological impact of pulmonary embolism: A mixed-methods study. Res. Pract. Thromb. Haemost. 5, 301–307. https://doi.org/10.1002/rth2.12484 (2021).
doi: 10.1002/rth2.12484 pubmed: 33733029 pmcid: 7938621
Winter, M.-P., Schernthaner, G. H. & Lang, I. M. Chronic complications of venous thromboembolism. J. Thromb. Haemost. 15, 1531–1540. https://doi.org/10.1111/jth.13741 (2017).
doi: 10.1111/jth.13741 pubmed: 28762624
Barco, S., Woersching, A. L., Spyropoulos, A. C., Piovella, F. & Mahan, C. E. European Union-28: An annualised cost-of-illness model for venous thromboembolism. Thromb. Haemost. 115, 800–808. https://doi.org/10.1160/TH15-08-0670 (2016).
doi: 10.1160/TH15-08-0670 pubmed: 26607486
Grosse, S. D., Nelson, R. E., Nyarko, K. A., Richardson, L. C. & Raskob, G. E. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb. Res. 137, 3–10. https://doi.org/10.1016/j.thromres.2015.11.033 (2016).
doi: 10.1016/j.thromres.2015.11.033 pubmed: 26654719
Mahan, C. E. et al. Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb. Haemost. 108, 291–302. https://doi.org/10.1160/TH12-03-0162 (2012).
doi: 10.1160/TH12-03-0162 pubmed: 22739656
Scheres, L. J. J., Lijfering, W. M. & Cannegieter, S. C. Current and future burden of venous thrombosis: Not simply predictable. Res. Pract. Thromb. Haemost. 2, 199–208. https://doi.org/10.1002/rth2.12101 (2018).
doi: 10.1002/rth2.12101 pubmed: 30046722 pmcid: 6055567
Kearon, C. et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: Guidance from the SSC of ISTH. J. Thromb. Haemost. 14, 1480–1483. https://doi.org/10.1111/jth.13336 (2016).
doi: 10.1111/jth.13336 pubmed: 27428935
Silverstein, M. D. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch. Intern. Med. 158, 585–593. https://doi.org/10.1001/archinte.158.6.585 (1998).
doi: 10.1001/archinte.158.6.585 pubmed: 9521222
Divo, M. J., Martinez, C. H. & Mannino, D. M. Ageing and the epidemiology of multimorbidity. Eur. Respir. J. 44, 1055–1068. https://doi.org/10.1183/09031936.00059814 (2014).
doi: 10.1183/09031936.00059814 pubmed: 25142482 pmcid: 4918092
United Nations Department of Economic and Social Affairs World Population Ageing 2020 Highlights: Living arrangements of older persons. (United Nations, 2021).
Apenteng, P. N. et al. Incidence of venous thromboembolism in care homes: a prospective cohort study. Br. J. Gen. Pract. 67, e130–e137. https://doi.org/10.3399/bjgp17X688873 (2017).
doi: 10.3399/bjgp17X688873 pubmed: 28093420 pmcid: 5308119
Petterson, T. M. et al. Venous thromboembolism (VTE) incidence and VTE-associated survival among Olmsted county residents of local nursing homes. Thromb. Haemost. 118, 1316–1328. https://doi.org/10.1055/s-0038-1660436 (2018).
doi: 10.1055/s-0038-1660436 pubmed: 29966167 pmcid: 6206861
von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344–349. https://doi.org/10.1016/j.jclinepi.2007.11.008 (2008).
doi: 10.1016/j.jclinepi.2007.11.008
Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic. Dis. 40, 373–383. https://doi.org/10.1016/0021-9681(87)90171-8 (1987).
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716
Wagner, G. et al. Epidemiology, risk profile, management, and outcome in geriatric patients with atrial fibrillation in two long-term care hospitals. Sci. Rep. 12, 18725. https://doi.org/10.1038/s41598-022-22013-6 (2022).
doi: 10.1038/s41598-022-22013-6 pubmed: 36333439 pmcid: 9636160
Coviello, V. & Boggess, M. Cumulative incidence estimation in the presence of competing risks. Stata J. 4, 103–112. https://doi.org/10.1177/1536867x0400400201 (2004).
doi: 10.1177/1536867x0400400201
Reardon, G. et al. Incidence of venous thromboembolism in nursing home residents. J. Am. Med. Dir. Associat. 14, 578–584. https://doi.org/10.1016/j.jamda.2013.02.003 (2013).
doi: 10.1016/j.jamda.2013.02.003
Gomes, J. P. et al. Incidence of venous thromboembolic events among nursing home residents. J. Gen. Intern. Med. 18, 934–936. https://doi.org/10.1046/j.1525-1497.2003.21133.x (2003).
doi: 10.1046/j.1525-1497.2003.21133.x pubmed: 14687280 pmcid: 1494943
Gatt, M. E., Paltiel, O. & Bursztyn, M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?. Thromb. Haemost. 91, 538–543 (2004).
doi: 10.1160/TH03-07-0481 pubmed: 14983230
Arpaia, G. et al. Risk of venous thromboembolism in patients nursed at home or in long-term care residential facilities. Int. J. Vasc. Med. 2011, 305027. https://doi.org/10.1155/2011/305027 (2011).
doi: 10.1155/2011/305027 pubmed: 21748017 pmcid: 3124858
Gross, J. S., Neufeld, R. R., Libow, L. S., Gerber, I. & Rodstein, M. Autopsy study of the elderly institutionalized patient: Review of 234 autopsies. Arch. Intern. Med. 148, 173–176. https://doi.org/10.1001/archinte.1988.00380010175018 (1988).
doi: 10.1001/archinte.1988.00380010175018 pubmed: 3337592
Haas, S. & Spyropoulos, A. C. Primary prevention of venous thromboembolism in long-term care: Identifying and managing the risk. Clin. Appl. Thromb./Hemost. 14, 149–158. https://doi.org/10.1177/1076029607311779 (2008).
doi: 10.1177/1076029607311779 pubmed: 18372276
Pai, M. & Douketis, J. D. Preventing venous thromboembolism in long-term care residents: Cautious advice based on limited data. Clevel. Clin. J. Med. 77, 123–130. https://doi.org/10.3949/ccjm.77a.09096 (2010).
doi: 10.3949/ccjm.77a.09096

Auteurs

Gernot Wagner (G)

Department for Evidence-Based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria.

Daniel Steiner (D)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Gerald Ohrenberger (G)

Haus der Barmherzigkeit Seeboeckgasse, Vienna, Austria.

Michael Smeikal (M)

Haus der Barmherzigkeit Tokiostraße, Vienna, Austria.

Christoph Gisinger (C)

Haus der Barmherzigkeit Seeboeckgasse, Vienna, Austria.
Haus der Barmherzigkeit Tokiostraße, Vienna, Austria.
Center for Geriatric Medicine and Geriatric Nursing, University for Continuing Education Krems, Krems, Austria.

Deddo Moertl (D)

Department of Internal Medicine 3, University Hospital St. Poelten, St. Poelten, Austria.
Karl Landsteiner University of Health Sciences, Krems, Austria.

Stephan Nopp (S)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Gerald Gartlehner (G)

Department for Evidence-Based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria.
Center for Public Health Methods, RTI International, Research Triangle Park, NC, USA.

Ingrid Pabinger (I)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Cihan Ay (C)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. cihan.ay@meduniwien.ac.at.
Department of Obstetrics, Gynecology and Perinatal Medicine, I. M., Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. cihan.ay@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH